about
Hospital days, hospitalization costs, and inpatient mortality among patients with mucormycosis: a retrospective analysis of US hospital discharge data.Trends in Hospitalizations Related to Invasive Aspergillosis and Mucormycosis in the United States, 2000-2013.Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates.Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of MucoralesEx vivo confocal microscopy: a new diagnostic technique for mucormycosis.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg?Mucormycosis at a tertiary care centre in Gujarat, India.Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis.Early Diagnosis of Cutaneous Mucormycosis Due to Lichtheimia corymbifera After a Traffic Accident.Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity.Apophysomyces variabilis: draft genome sequence and comparison of predictive virulence determinants with other medically important Mucorales.Species identification and delineation of pathogenic Mucorales by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.Activity of Isavuconazole against Opportunistic Fungal Pathogens from Two Mycology Reference LaboratoriesFungal Rhino-orbital Cerebritis in a Patient with Steroid-induced Ketoacidosis
P2860
Q30829283-B8A2AE42-81D2-4D26-83DB-D04C1871E1A9Q33629045-6EE52707-B69E-4464-A497-18C1F580EDA6Q33773267-D1989055-CA4D-42A3-8E60-EA5C2D4A403DQ35076896-92E69A4F-1500-45AA-8C79-DC7CEC3A38AAQ35823772-320632D5-5502-43D2-9E14-01B314427CCAQ38285488-054DCA11-E1CA-49E2-9F42-162D500ECB95Q38802183-77DB7E88-19B6-4C46-A816-C2D420C32E18Q38919115-DFFAA91A-A625-4CBB-BFA1-6AE045340B07Q40159963-25A20629-6AC5-496F-97C0-9445529A80DFQ41003543-BAACC01F-F9CA-4E70-B25F-64E436EF5285Q41545511-54FC3C34-C37B-4F4F-A2DB-2ED9747B31DAQ41704770-FB7F2F89-CB49-452C-BBDE-1E5025865472Q50045135-D28C4C63-99F2-41FD-9449-38591E14F907Q58701180-32BC98AC-7616-47FE-BFAE-A3ACFAA6C560Q59137700-7A9C3DE5-7F3A-43F8-A949-F4CB4FC19353
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epidemiology of mucormycosis in Europe.
@en
type
label
Epidemiology of mucormycosis in Europe.
@en
prefLabel
Epidemiology of mucormycosis in Europe.
@en
P356
P1476
Epidemiology of mucormycosis in Europe.
@en
P2093
P356
10.1111/1469-0691.12563
P478
20 Suppl 6
P577
2014-03-06T00:00:00Z